Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations-Reference-Cited by-同舟云学术

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations

Published:2011-12 Issue:3 Volume:74 Page:401-404
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kudo Keita,Ohyanagi Fumiyoshi,Horiike Atushi,Miyauchi Eisaku,Yanagitani Noriko,Hoshi Rira,Satoh Yukitoshi,Motoi Noriko,Hamanaka Wakako,Ishikawa Yuichi,Mun Mingyon,Sakao Yukinori,Okumura Sakae,Nakagawa Ken,Horai Takeshi,Nishio Makoto

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. The editorial board of the cancer statistics in Japan,2007

2. Histological typing of lung and pleural tumors;Travis,1999

3. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology;Iyoda;Cancer,2001

4. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases;Takei;J Thorac Cardiovasc Surg,2002

5. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases;Travis;Am J Surg Pathol,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of pulmonary endarterectomy for patients with pulmonary artery sarcoma;Frontiers in Cardiovascular Medicine;2024-07-02

2. Sensitive electrochemiluminescence immunosensor based on a novel luminescent europium metal–organic framework and antenna effect for detecting pro-gastrin-releasing peptide;Talanta;2024-04

3. Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report;Respiratory Medicine Case Reports;2023

4. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?;Neoplasma;2022

5. Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations;Cancer Management and Research;2021-01